Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major.
暂无分享，去创建一个
Y. Bertrand | R. Galanello | A. Piga | F. Longo | G. Forni | D. Alberti | H. Maseruka | Antonietta Zappu | M. Foschini | G. Leoni | R. Belleli | R. Sechaud | N. Hewson | A. Lavagetto | E. Bordone | Yves Bertrand | Elena Bordone | Nicola Hewson | Daniele Alberti